INIS
patients
100%
risks
52%
diseases
37%
levels
33%
data
29%
comparative evaluations
28%
thrombosis
27%
glucose
24%
populations
23%
veins
22%
therapy
22%
plasma
21%
reviews
17%
biological markers
17%
mortality
15%
symptoms
15%
sex
15%
inflammation
14%
cardiovascular diseases
14%
blood
14%
metabolism
13%
insulin
12%
control
12%
surgery
12%
management
12%
men
11%
diabetes mellitus
11%
values
11%
anticoagulants
11%
women
11%
adults
11%
brain
11%
proteins
11%
interventions
11%
thrombin
10%
kidneys
10%
incidents
9%
humans
9%
arteries
9%
ischemia
9%
blood pressure
9%
performance
9%
stiffness
8%
volume
8%
intake
8%
assessments
8%
vessels
7%
adjustments
7%
cancer
7%
design
7%
regression analysis
7%
receptors
7%
thickness
7%
quality of life
7%
concentration
7%
atherosclerosis
7%
sensitivity
7%
tissues
7%
netherlands
7%
people
7%
obesity
6%
covid-19
6%
genes
6%
hazards
6%
range
6%
repair
6%
diet
6%
liver
6%
monitoring
6%
prediction
5%
injuries
5%
hospitals
5%
interactions
5%
nervous system diseases
5%
reduction
5%
coronaries
5%
guidelines
5%
pulses
5%
drugs
5%
hypertension
5%
weight
5%
lipids
5%
Keyphrases
Maastricht
66%
Type 2 Diabetes Mellitus (T2DM)
40%
Platelets
14%
Diabetes
13%
Pre-diabetes (pre-DM)
12%
Deep Vein Thrombosis
11%
Confidence Interval
11%
Post-thrombotic Syndrome
10%
Cardiovascular Risk
10%
Depressive Symptoms
9%
Cardiovascular Disease
9%
Meta-analysis
9%
Thrombosis
8%
Atrial Fibrillation
7%
Netherlands
7%
Randomized Controlled Trial
7%
Thrombin Generation
7%
Normal Glucose Tolerance
7%
Advanced Glycation End Products
6%
Type 1 Diabetes Mellitus (T1DM)
6%
Microvascular Dysfunction
6%
Non-associated
6%
Metformin
6%
Venous Thromboembolism
6%
Systematic Meta-analysis
5%
Arterial Stiffness
5%
Hemoglobin A1c (HbA1c)
5%
Hemostasis
5%
Thrombus Formation
5%
Methylglyoxal
5%
Dutch
5%
Odds Ratio
5%
Anticoagulation
5%
Risk Factors
5%
Endothelial Dysfunction
5%
Type I Diabetes
5%
Hazard Ratio
5%
COVID-19
5%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
31%
Diabetes
13%
Vein Occlusion
12%
Impaired Glucose Tolerance
12%
Deep Vein Thrombosis
12%
Cardiovascular Disease
11%
Biological Marker
11%
Platelet
11%
Thrombosis
11%
Post-Thrombotic Syndrome
10%
Glucose Metabolism
9%
COVID-19
8%
Cardiovascular Risk
8%
Cardiovascular System
8%
Depressive Disorder
7%
Arterial Stiffness
7%
Venous Thromboembolism
7%
Anticoagulation
7%
Cohort Analysis
7%
Stenting
6%
Atrial Fibrillation
6%
Diseases
6%
Meta-Analysis
6%
Systematic Review
6%
Randomized Controlled Trial
6%
Quality of Life
6%
Antithrombotic
6%
Endothelial Dysfunction
5%
Blood Clot Lysis
5%
Thrombin
5%
Physical Activity
5%
Blood Clotting
5%
Atherosclerosis
5%
Pulse Wave Velocity
5%